Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, et al.
Vaccine (2022) Vol. 40, Iss. 24, pp. 3320-3329
Open Access | Times Cited: 10

Showing 10 citing articles:

Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 5, pp. 685-685
Open Access | Times Cited: 9
Safety and immunogenicity of Ad5-nCoV administered intradermally by needle-free injector in rats
Li Chen, Xiaoyin Zhang, Lairun Jin, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
Ritthideach Yorsaeng, Kamolthip Atsawawaranunt, Nungruthai Suntronwong, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1184-1184
Open Access | Times Cited: 10
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose
Geert V.T. Roozen, Manon L. M. Prins, Corine Prins, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 2
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, et al.
Vaccine X (2022) Vol. 12, pp. 100211-100211
Open Access | Times Cited: 7
Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine
Yutthapong Temtanakitpaisan, Suchaorn Saengnipanthkul, Nataporn Sarakosol, et al.
Vaccine X (2022) Vol. 12, pp. 100242-100242
Open Access | Times Cited: 7
Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
Stephanie Montero, Diego Urrunaga‐Pastor, Percy Soto-Becerra, et al.
Vaccine X (2023) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 2
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance
Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, et al.
Vaccine X (2023) Vol. 15, pp. 100367-100367
Open Access | Times Cited: 2
Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket – A Retrospective Cohort Study
Withita Jangiam, Kusuma Swangpun, Sopon Iamsirithaworn, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107179-107179
Closed Access
Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial
Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 73-73
Open Access
Page 1

Scroll to top